SCHEMBL26040679

SCHEMBL26040679

CCCCc1cc(C2CCN(C)CC2C)c(C)cc1N

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.34
SIGMAR1 Q99720 1/20 0.33
SKP2 Q13309 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
SLC6A3 Q01959 1/20 0.31
PRKCQ Q04759 1/20 0.30
LRRK2 Q5S007 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26042003 0.81 VDR (0.36) VDRSKP2HRH4SLC6A3
SCHEMBL17304240 0.76 HTR2C (0.33) SIGMAR1PRKCQ
SCHEMBL23762991 0.72 CA12 (0.41) SIGMAR1PRKCQ
SCHEMBL26039913 0.69 HTR2C (0.40) VDRSKP2
SCHEMBL18536009 0.68 SKP2 (0.50) VDRSKP2
SCHEMBL24328529 0.67 HTR1D (0.39)
SCHEMBL2881923 0.66 SIGMAR1 (0.50) SIGMAR1PRKCQ
SCHEMBL833088 0.64 SKP2 (0.47) VDRSKP2
SCHEMBL26041148 0.63 VDR (0.33) VDRSKP2
SCHEMBL17304320 0.63 LRRK2 (0.40) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150592-B1 ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF SHANGHAI EMERALD WELLCARES PHARMACEUTICAL CO LTD (CN) 2023-08-30 EP disclosed